Pretransplant cryptococcosis and outcome after liver transplantation

TitlePretransplant cryptococcosis and outcome after liver transplantation
Publication TypeJournal Article
Year of Publication2010
AuthorsSifri CD, Sun HY, Cacciarelli TV, Wispelwey B, Pruett TL, Singh N
JournalLiver Transpl
Volume16
Issue4
Pagination499 - 502
Date PublishedApr
ISSN1527-6473 (Electronic) 1527-6465 (Linking)
Accession Number20373460
KeywordsAntifungal Agents / therapeutic use, Cryptococcosis / *complications, Fibrosis / *complications / therapy, Fluconazole / therapeutic use, Humans, Immunosuppressive Agents / therapeutic use, Liver Failure / *complications / *therapy, Liver Transplantation / *methods, Male, Middle Aged, Preoperative Period, Time Factors, Treatment Outcome
Abstract

The posttransplant outcomes and optimal management of patients with end-stage liver disease who develop cryptococcosis prior to transplantation have not been defined. We discuss these issues in the context of successful liver transplantation and pretransplant cryptococcal disease. Our report suggests that liver transplantation may be cautiously considered under the umbrella of fluconazole therapy in patients with end-stage liver disease and pretransplant cryptococcosis, provided that disease control is achieved with adequate treatment before transplantation.

DOI10.1002/lt.22024
Short TitlePretransplant cryptococcosis and outcome after liver transplantation
Notify Library Reference ID1408

Related Incidents